Ali Ansary, Ozette Technologies CEO

A new AI start­up, launched with a trio of Fred Hutch vets, wants to give a 'zoomed-in' view of can­cer cells

Ali Ansary, a trained physi­cian, had re­al­ized by 2018 that can­cers would no longer be treat­ed just with tra­di­tion­al chemother­a­py and ra­di­a­tions. Im­munother­a­py was be­com­ing big, and yet there was no way for doc­tors to get a com­plete pic­ture of how im­mune cells worked at the cel­lu­lar lev­el when used for can­cer ther­a­py, he says.

“How do we get to know more in­for­ma­tion about this sys­tem that is more than in­flam­ma­to­ry mark­ers?” he won­dered.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.